The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
5 01 ACQUISITION CORP COM CL A 33836P105 3,586 365,126 SH   SOLE   365,126 0 0
AKOUOS INC COM 00973J101 48,016 4,135,784 SH   SOLE   4,135,784 0 0
ARVINAS INC COM 04335A105 32,872 400,000 SH   SOLE   400,000 0 0
AVIDITY BIOSCIENCES INC COM 05370A108 13,683 555,555 SH   SOLE   555,555 0 0
CABALETTA BIO INC COM 12674W109 28,689 2,359,263 SH   SOLE   2,359,263 0 0
CIDARA THERAPEUTICS INC COM 171757107 2,541 1,134,511 SH   SOLE   1,134,511 0 0
CRINETICS PHARMACEUTICALS IN COM 22663K107 28,676 1,362,286 SH   SOLE   1,362,286 0 0
HOMOLOGY MEDICINES INC COM 438083107 35,698 4,535,919 SH   SOLE   4,535,919 0 0
IDEAYA BIOSCIENCES INC COM 45166A102 35,637 1,398,066 SH   SOLE   1,398,066 0 0
IMPEL NEUROPHARMA INC COM 45258K109 35,137 2,884,791 SH   SOLE   2,884,791 0 0
IVERIC BIO INC COM 46583P102 12,505 770,000 SH   SOLE   770,000 0 0
JANUX THERAPEUTICS INC COM 47103J105 9,653 446,266 SH   SOLE   446,266 0 0
RALLYBIO CORP COM 75120L100 73,673 4,190,724 SH   SOLE   4,190,724 0 0
SCPHARMACEUTICALS INC COM 810648105 25,479 3,831,474 SH   SOLE   3,831,474 0 0
SILVERBACK THERAPEUTICS INC COM 82835W108 1,694 169,748 SH   SOLE   169,748 0 0
VOR BIOPHARMA INC COM 929033108 104,937 6,692,429 SH   SOLE   6,692,429 0 0